Skip links

Xenpozyme® (olipudase alfa-rpcp)

Full Name Xenpozyme® (olipudase alfa-rpcp)
Drug Xenpozyme
Manufacturer Sanofi Genzyme
Route of Administration Intravenous
Site of Care Home or Healthcare Facility
Approved Indication Treatment of non–central nervous system manifestations of acid sphingomyelinase deficiency (ASMD) in adult and pediatric patients
Disease Acid Sphingomyelinase Deficiency (ASMD)
Therapeutic Area Neurology, Genetics
Enrollment Form Link Xenpozyme Enrollment Form
Phone Number 800-240-9572
Fax Number 877-220-7581
Product Website xenpozyme.com